Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome—A Randomized Controlled Trial

Sympathetic nervous system (SNS) activity is increased in polycystic ovary syndrome (PCOS). Moxonidine is a centrally acting sympatholytic drug with known beneficial effects on hypertension, insulin sensitivity, dyslipidemia and inflammation. In this double-blind placebo controlled randomized clinic...

Полное описание

Библиографические подробности

Главные авторы:	Soulmaz Shorakae, Elisabeth A. Lambert, Eveline Jona, Carolina Ika Sari, Barbora de Courten, John B. Dixon, Gavin W. Lambert, Helena J. Teede
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2018-10-01
Серии:	Frontiers in Physiology
Предметы:	polycystic ovary syndrome sympathetic nervous system insulin resistance moxonidine randomized controlled trial
Online-ссылка:	https://www.frontiersin.org/article/10.3389/fphys.2018.01486/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!